Core Insights - Cameco, a Canada-based uranium refiner, reported third-quarter earnings that missed analyst estimates, with EPS at 5 cents, an improvement from a slight loss a year ago, while revenue fell 16% to $436.7 million [1] Group 1: Company Performance - Cameco's Q3 EPS of 5 cents indicates a recovery from the previous year's loss, but the revenue decline of 16% to $436.7 million raises concerns about its sales performance [1] - Despite the earnings miss, Cameco maintains a strong position in the nuclear sector, claiming to be "at the forefront of the global nuclear resurgence" [1] Group 2: Market Context - The nuclear sector is experiencing a resurgence, with Cameco positioned to benefit from this trend, highlighting the potential for future growth despite current earnings challenges [1] - Related news indicates that BWX Technologies, another player in the nuclear sector, reported third-quarter earnings, suggesting ongoing activity and interest in the industry [2]

Financial Performance - Q3 FY25 revenue reached $3.6 billion, a 2% increase compared to $3.49 billion in Q3 FY24[43] - Adjusted EBITDA for Q3 FY25 was $274 million, up 7% from $257 million in Q3 FY24[43] - Adjusted Diluted EPS increased to $0.56 in Q3 FY25, compared to $0.51 in Q3 FY24[43] - Free Cash Flow for Q3 FY25 was $100 million[13] Business Development and Backlog - Backlog remained strong at $45 billion[13] - The company secured a Space Force Range Contract worth $4 billion, although it is currently under protest and not included in the backlog[22] - The company received multiple intelligence awards totaling over $500 million[24] - On-contract growth modifications and extensions provided a $2+ billion benefit in bookings[25] Debt and Deleveraging - Net leverage reduced to 3.5x, driven by operating and investing activity contributions[12, 52] - The company targets net leverage of less than 3x by FY26 year-end[54] - The company has $738 million in cash on hand and an $850 million undrawn revolving credit facility[57] Guidance - The company raised its FY25 organic revenue guidance to $13.975 - $14.175 billion[12, 58] - The company anticipates interest expense of $345M - $355M and capital expenditures of $35M - $40M for FY25[66] Nuclear Market - The global nuclear market demand is projected to reach $91 billion by FY2026 and $68 billion by FY2030[33] - The company's total addressable market in the nuclear sector is expected to more than double by 2035, reaching ~$20 billion[40]